Cytosorbents (CTSO) Change in Receivables (2011 - 2026)
Cytosorbents (CTSO) reported Change in Receivables of -$310000.0 for Q1 2026, down 487.5% on a YoY basis from $80000.0 in Q1 2025, and down 326.28% quarter-over-quarter from $137000.0 in Q4 2025.
Cytosorbents (CTSO) Change in Receivables (2011 - 2026) Analysis & Trends
Cytosorbents has reported Change in Receivables for 16 years, with the latest figure at -$310000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 487.5% year-over-year to -$310000.0; the trailing twelve-month figure through Mar 2026 stood at -$813000.0 (down 185.43% YoY), and the FY2025 full-year result was -$423000.0, down 124.59% from the prior year.
- Change in Receivables for Q1 2026 stood at -$310000.0, down from $137000.0 in the prior quarter.
- The five-year high for Change in Receivables was $1.4 million in Q2 2023, with the low at -$1.3 million in Q3 2024.
- Historically, Change in Receivables has averaged $148296.4 across 5 years, with a median of $80000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 752.71% — and 2023, when it sank 701.71%.
- Cytosorbents' Change in Receivables stood at $428400.0 in 2022, then tumbled by 183.49% to -$357670.0 in 2023, then surged by 405.03% to $1.1 million in 2024, then sank by 87.44% to $137000.0 in 2025, then slumped by 326.28% to -$310000.0 in 2026.
- The last three Change in Receivables figures came in at -$310000.0 (Q1 2026), $137000.0 (Q4 2025), and -$303000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -310,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -310,000.00 |
| Mar 31, 2026 | -310,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | -303,000.00 |
| Sep 30, 2025 | -303,000.00 |
| Jun 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -337,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Mar 31, 2025 | 80,000.00 |
| Dec 31, 2024 | 1.09 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 848,330.00 |
| Mar 31, 2024 | 848,330.00 |
| Dec 31, 2023 | -357,670.00 |
| Dec 31, 2023 | -357,670.00 |